Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00267670 · ClinicalTrials.gov registry record · Phase 2
Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH
A Phase 2 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 2
- Development phase
- 26
- Enrollment target
NCT00267670 is a Phase 2 study that has completed, run by Northwestern University. The registered enrollment target is 26 participants.
The verdict
NCT00267670, a Phase 2 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the potential benefit of the medication, pentoxifylline, for the treatment of NASH.
Interventions
- DRUG Placebo
- DRUG Pentoxifylline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2005-03 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00267670
The ClinicalTrials.gov registry entry for NCT00267670 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00267670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00267670 about?
NCT00267670 is a clinical study titled "Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH". The purpose of this study is to explore the potential benefit of the medication, pentoxifylline, for the treatment of NASH.
What is the current status of trial NCT00267670?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 2005-03. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00267670?
The interventions under investigation include: Placebo (DRUG), Pentoxifylline (DRUG).
Who is sponsoring clinical trial NCT00267670?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.